Top compounds associated with response to LSM3


Feature Type Standardized
Nominal ANOVA
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.083 0.03
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.081 0.03
mRNA Tipifarnib GDSC1000 pan-cancer AAC -0.081 0.03
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.078 0.03
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.07 0.03
mRNA KIN001-270 GDSC1000 pan-cancer AAC 0.077 0.03
mRNA CH5424802 GDSC1000 pan-cancer AAC -0.076 0.03
mRNA GSK2636771 CTRPv2 pan-cancer AAC -0.094 0.03
mRNA JW-74 CTRPv2 pan-cancer AAC -0.1 0.03
mRNA BRD-K33199242 CTRPv2 pan-cancer AAC -0.082 0.03
Download CSV